| Chain A, HADH2 protein | 11 | 0 | 0 | 11 |
| Chain B, HADH2 protein | 11 | 0 | 0 | 11 |
| Luciferase | 8 | 0 | 0 | 8 |
| interleukin 8 | 6 | 0 | 0 | 6 |
| RAR-related orphan receptor gamma | 23 | 0 | 0 | 23 |
| GLI family zinc finger 3 | 22 | 0 | 0 | 22 |
| AR protein | 33 | 0 | 0 | 33 |
| thyroid stimulating hormone receptor | 22 | 0 | 0 | 22 |
| estrogen receptor 2 (ER beta) | 14 | 0 | 0 | 14 |
| nuclear receptor subfamily 1, group I, member 3 | 23 | 0 | 0 | 23 |
| progesterone receptor | 14 | 0 | 0 | 14 |
| glucocorticoid receptor [Homo sapiens] | 28 | 0 | 0 | 28 |
| retinoic acid nuclear receptor alpha variant 1 | 24 | 0 | 0 | 24 |
| retinoid X nuclear receptor alpha | 19 | 0 | 0 | 19 |
| estrogen-related nuclear receptor alpha | 32 | 0 | 0 | 32 |
| farnesoid X nuclear receptor | 16 | 0 | 0 | 16 |
| pregnane X nuclear receptor | 25 | 0 | 0 | 25 |
| estrogen nuclear receptor alpha | 43 | 0 | 0 | 43 |
| peroxisome proliferator-activated receptor delta | 14 | 0 | 0 | 14 |
| peroxisome proliferator activated receptor gamma | 18 | 0 | 0 | 18 |
| aryl hydrocarbon receptor | 7 | 0 | 0 | 7 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 16 | 0 | 0 | 16 |
| Histone H2A.x | 12 | 0 | 0 | 12 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 7 | 0 | 0 | 7 |
| thyroid hormone receptor beta isoform 2 | 23 | 0 | 0 | 23 |
| heat shock protein beta-1 | 6 | 0 | 0 | 6 |
| mitogen-activated protein kinase 1 | 12 | 0 | 0 | 12 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 27 | 0 | 0 | 27 |
| Voltage-dependent calcium channel gamma-2 subunit | 12 | 0 | 0 | 12 |
| Cellular tumor antigen p53 | 26 | 0 | 0 | 26 |
| Glutamate receptor 2 | 12 | 2 | 1 | 15 |
| Nuclear receptor ROR-gamma | 6 | 0 | 0 | 6 |
| Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 10 | 0 | 0 | 10 |
| Ataxin-2 | 13 | 0 | 0 | 13 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 17 | 0 | 0 | 17 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 11 | 0 | 0 | 11 |
| aldehyde dehydrogenase 1 family, member A1 | 19 | 0 | 0 | 19 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 22 | 0 | 0 | 22 |
| thyroid hormone receptor beta isoform a | 12 | 0 | 0 | 12 |
| cytochrome P450 3A4 isoform 1 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit pi | 7 | 9 | 0 | 16 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 7 | 9 | 0 | 16 |
| Gamma-aminobutyric acid receptor subunit delta | 7 | 9 | 0 | 16 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 7 | 9 | 1 | 17 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 7 | 9 | 0 | 16 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 7 | 9 | 0 | 16 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 7 | 9 | 0 | 16 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 7 | 9 | 0 | 16 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 7 | 9 | 0 | 16 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 7 | 9 | 0 | 16 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 7 | 9 | 0 | 16 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 7 | 10 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 7 | 9 | 0 | 16 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 7 | 9 | 1 | 17 |
| GABA theta subunit | 7 | 9 | 0 | 16 |
| Gamma-aminobutyric acid receptor subunit epsilon | 7 | 9 | 0 | 16 |
| dopamine D1 receptor | 4 | 0 | 0 | 4 |
| thioredoxin reductase | 24 | 0 | 0 | 24 |
| GLS protein | 10 | 0 | 0 | 10 |
| Thrombopoietin | 5 | 0 | 0 | 5 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 6 | 0 | 0 | 6 |
| cytochrome P450 2D6 isoform 1 | 8 | 0 | 0 | 8 |
| cytochrome P450 2C19 precursor | 5 | 0 | 0 | 5 |
| ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
| histone acetyltransferase KAT2A isoform 1 | 8 | 0 | 0 | 8 |
| lethal factor (plasmid) | 8 | 0 | 0 | 8 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| Spike glycoprotein | 9 | 1 | 2 | 12 |
| ATP-dependent phosphofructokinase | 11 | 0 | 0 | 11 |
| Chain A, Cruzipain | 5 | 0 | 0 | 5 |
| USP1 protein, partial | 11 | 0 | 0 | 11 |
| Microtubule-associated protein tau | 11 | 0 | 0 | 11 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 18 | 0 | 0 | 18 |
| cytochrome P450 2D6 | 9 | 0 | 0 | 9 |
| glucocerebrosidase | 4 | 0 | 0 | 4 |
| IDH1 | 10 | 0 | 0 | 10 |
| euchromatic histone-lysine N-methyltransferase 2 | 31 | 0 | 0 | 31 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
| chromobox protein homolog 1 | 15 | 0 | 0 | 15 |
| transcriptional regulator ERG isoform 3 | 6 | 0 | 0 | 6 |
| geminin | 28 | 0 | 0 | 28 |
| peripheral myelin protein 22 | 15 | 0 | 0 | 15 |
| survival motor neuron protein isoform d | 12 | 0 | 0 | 12 |
| lamin isoform A-delta10 | 24 | 0 | 0 | 24 |
| Potassium channel subfamily K member 2 | 0 | 2 | 1 | 3 |
| Rap guanine nucleotide exchange factor 3 | 4 | 0 | 0 | 4 |
| Potassium voltage-gated channel subfamily A member 3 | 0 | 0 | 1 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 2 |
| Pteridine reductase 1 | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 10 | 0 | 10 |
| Cytochrome P450 2A6 | 0 | 4 | 0 | 4 |
| Cytochrome P450 2A5 | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 11 | 0 | 0 | 11 |
| hypoxia-inducible factor 1 alpha subunit | 7 | 0 | 0 | 7 |
| SMAD family member 2 | 7 | 0 | 0 | 7 |
| SMAD family member 3 | 7 | 0 | 0 | 7 |
| caspase 7, apoptosis-related cysteine protease | 6 | 0 | 0 | 6 |
| caspase-3 | 6 | 0 | 0 | 6 |
| thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
| activating transcription factor 6 | 4 | 0 | 0 | 4 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 12 | 0 | 0 | 12 |
| Caspase-7 | 4 | 0 | 0 | 4 |
| caspase-3 | 4 | 0 | 0 | 4 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
| Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 6 | 0 | 0 | 6 |
| Chain A, Endochitinase | 0 | 2 | 0 | 2 |
| Chain A, Endochitinase | 0 | 2 | 0 | 2 |
| Chain A, Endochitinase | 0 | 2 | 0 | 2 |
| Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| GALC protein | 3 | 0 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| arylsulfatase A | 12 | 0 | 0 | 12 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Bloom syndrome protein isoform 1 | 12 | 0 | 0 | 12 |
| muscleblind-like protein 1 isoform 1 | 7 | 0 | 0 | 7 |
| ATP-binding cassette sub-family C member 3 | 0 | 28 | 0 | 28 |
| Multidrug resistance-associated protein 4 | 0 | 28 | 0 | 30 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 4 |
| Carbonic anhydrase 12 | 0 | 2 | 1 | 7 |
| Prolyl endopeptidase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
| Bile salt export pump | 0 | 34 | 0 | 34 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Renin | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 1 | 0 | 8 | 1 | 17 |
| Carbonic anhydrase 2 | 0 | 8 | 2 | 17 |
| Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
| Cytochrome P450 1A2 | 0 | 2 | 1 | 4 |
| Carbonic anhydrase 3 | 0 | 2 | 1 | 7 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 8 | 0 | 9 |
| Steryl-sulfatase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 5 | 0 | 6 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 6 | 1 | 8 |
| Cytochrome P450 2C9 | 0 | 8 | 0 | 9 |
| 5-hydroxytryptamine receptor 2A | 0 | 5 | 0 | 5 |
| Androgen receptor | 0 | 4 | 0 | 4 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 1 | 2 | 4 |
| Carbonic anhydrase 4 | 0 | 5 | 1 | 9 |
| Carbonic anhydrase 6 | 0 | 3 | 1 | 7 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 3 | 1 | 6 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 0 | 0 | 1 |
| Endochitinase | 0 | 2 | 0 | 2 |
| Adenosine receptor A2a | 0 | 3 | 1 | 6 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 3 | 0 | 3 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 1 | 8 |
| Carbonic anhydrase | 0 | 4 | 0 | 6 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 3 |
| Carbonic anhydrase 7 | 0 | 2 | 1 | 6 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 3 | 1 | 0 | 4 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 3 |
| D(2) dopamine receptor | 0 | 5 | 0 | 6 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 7 | 1 | 10 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 9 | 0 | 3 | 1 | 8 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 3 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 4 |
| Carbonic anhydrase | 0 | 1 | 0 | 4 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 4 | 0 | 4 |
| Renin | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 3 |
| Endochitinase A1 | 0 | 2 | 0 | 2 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 2 | 1 | 5 |
| Canalicular multispecific organic anion transporter 1 | 0 | 28 | 0 | 28 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 15 | 0 | 3 | 0 | 6 |
| Acidic mammalian chitinase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 5 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 14 | 0 | 2 | 1 | 7 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 1 | 8 |
| Alcohol dehydrogenase E chain | 0 | 1 | 0 | 1 |
| Alcohol dehydrogenase S chain | 0 | 1 | 0 | 1 |
| Fibroblast growth factor receptor 4 | 0 | 1 | 0 | 2 |
| Chain E, Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
| Chain A, Ferritin light chain | 8 | 0 | 0 | 8 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| phosphopantetheinyl transferase | 13 | 0 | 0 | 13 |
| TDP1 protein | 29 | 0 | 0 | 29 |
| Smad3 | 3 | 0 | 0 | 3 |
| EWS/FLI fusion protein | 17 | 0 | 0 | 17 |
| hemoglobin subunit beta | 3 | 0 | 0 | 3 |
| atrial natriuretic peptide receptor 1 precursor | 3 | 0 | 0 | 3 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
| Solute carrier family 22 member 1 | 0 | 5 | 0 | 8 |
| Bile salt export pump | 0 | 11 | 0 | 11 |
| Purine nucleoside phosphorylase | 0 | 2 | 0 | 2 |
| Thymidine kinase, cytosolic | 0 | 3 | 0 | 5 |
| POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 5 | 0 | 5 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 1 | 0 | 3 |
| Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 4 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 4 |
| Thymidine kinase | 0 | 2 | 0 | 2 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain B, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
| Chain A, tRNA (guanine-N(1)-)-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Uncharacterized protein MJ0883 | 0 | 0 | 1 | 1 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 6 | 0 | 0 | 6 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 2 | 2 |
| flap endonuclease 1 | 8 | 0 | 0 | 8 |
| nuclear receptor ROR-gamma isoform 1 | 10 | 0 | 0 | 10 |
| high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
| Sodium/nucleoside cotransporter 1 | 0 | 2 | 0 | 2 |
| Calcium dependent protein kinase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
| Sodium/nucleoside cotransporter 2 | 0 | 2 | 0 | 2 |
| Epidermal growth factor receptor | 0 | 5 | 0 | 5 |
| Phosphoglycerate kinase 1 | 0 | 1 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Avidin | 0 | 0 | 1 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase | 0 | 2 | 0 | 2 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 2 | 0 | 2 |
| Insulin receptor | 0 | 0 | 0 | 1 |
| Phosphoglycerate kinase 2 | 0 | 1 | 0 | 1 |
| Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 2 |
| Platelet-derived growth factor receptor beta | 0 | 0 | 0 | 1 |
| Adenosine receptor A3 | 0 | 3 | 2 | 6 |
| Heat shock 70 kDa protein 1A | 0 | 1 | 0 | 1 |
| Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
| Fibroblast growth factor receptor 1 | 0 | 0 | 0 | 1 |
| Inosine-5'-monophosphate dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Endoplasmin | 0 | 1 | 1 | 2 |
| Inosine-5'-monophosphate dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Fibroblast growth factor receptor 2 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 3 | 0 | 0 | 0 | 1 |
| Streptavidin | 0 | 0 | 1 | 1 |
| Adenosylhomocysteinase | 0 | 0 | 0 | 3 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 3 | 2 | 6 |
| Adenosine receptor A2b | 0 | 0 | 1 | 2 |
| Adenosine receptor A2b | 0 | 1 | 1 | 2 |
| Adenylate kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 3 | 2 | 6 |
| Adenylate kinase isoenzyme 1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 0 | 1 | 1 |
| Adenosine kinase | 0 | 0 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Equilibrative nucleoside transporter 2 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 3 |
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | 0 | 1 | 0 | 1 |
| Equilibrative nucleoside transporter 1 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 3 |
| Solute carrier family 28 member 3 | 0 | 2 | 0 | 2 |
| Adenosine kinase | 0 | 1 | 0 | 2 |
| Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 3 |
| 5-methylthioadenosine/S-adenosylhomocysteine deaminase | 0 | 0 | 0 | 1 |
| Adenosine transporter 1 | 0 | 0 | 0 | 1 |
| Bromodomain-containing protein 4 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 6 | 3 | 9 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 6 | 2 | 8 |
| Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 6 | 3 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 6 | 3 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 6 | 2 | 8 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 6 | 1 | 7 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 14 | 0 | 0 | 14 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| Polyphenol oxidase 2 | 0 | 2 | 0 | 3 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 1 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 4 | 2 | 6 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 6 | 0 | 1 | 2 | 4 |
| Excitatory amino acid transporter 4 | 0 | 2 | 0 | 2 |
| Glutamate transporter homolog | 0 | 0 | 1 | 1 |
| N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 6 | 1 | 9 |
| Excitatory amino acid transporter 1 | 0 | 3 | 0 | 4 |
| Excitatory amino acid transporter 2 | 0 | 3 | 0 | 4 |
| Excitatory amino acid transporter 3 | 0 | 3 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 6 | 1 | 9 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 6 | 1 | 9 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 2 | 4 |
| Metabotropic glutamate receptor 2 | 0 | 1 | 2 | 4 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 6 | 1 | 9 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 6 | 1 | 9 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 6 | 1 | 9 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 9 | 0 | 0 | 9 |
| GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
| ras protein, partial | 0 | 0 | 1 | 1 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| Rac1 protein | 0 | 0 | 1 | 1 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
| DNA polymerase iota isoform a (long) | 10 | 0 | 0 | 10 |
| DNA polymerase kappa isoform 1 | 8 | 0 | 0 | 8 |
| muscarinic acetylcholine receptor M1 | 11 | 0 | 0 | 11 |
| Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
| Integrin beta-3 | 4 | 1 | 1 | 6 |
| Myeloperoxidase | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 4 | 1 | 1 | 6 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
| Sigma non-opioid intracellular receptor 1 | 0 | 3 | 1 | 4 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 1 | 3 |
| Chain A, Betaine ABC transporter permease and substrate binding protein | 0 | 0 | 1 | 1 |
| Chain A, Osmoprotection protein (ProX) | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 2 | 2 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 2 | 2 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 2 | 2 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 2 | 2 |
| Proton-coupled amino acid transporter 1 | 0 | 4 | 0 | 5 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
| vitamin D3 receptor isoform VDRA | 7 | 0 | 0 | 7 |
| caspase-1 isoform alpha precursor | 2 | 0 | 0 | 2 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| Inositol monophosphatase 1 | 4 | 0 | 0 | 4 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 4 | 0 | 7 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 4 | 0 | 7 |
| Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| PPM1D protein | 5 | 0 | 0 | 5 |
| Interferon beta | 13 | 0 | 0 | 13 |
| Vitamin D-binding protein | 0 | 0 | 1 | 1 |
| Androgen receptor | 0 | 3 | 0 | 3 |
| Vitamin D3 receptor | 0 | 2 | 3 | 6 |
| Vitamin D3 receptor | 0 | 1 | 1 | 3 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 3 | 3 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 1 | 1 | 2 |
| Transporter | 0 | 2 | 0 | 2 |
| Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
| DNA topoisomerase | 0 | 1 | 0 | 1 |
| 15-lipoxygenase, partial | 6 | 0 | 0 | 6 |
| ATAD5 protein, partial | 7 | 0 | 0 | 7 |
| Fumarate hydratase | 3 | 0 | 0 | 3 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| polyprotein | 3 | 0 | 0 | 3 |
| 67.9K protein | 8 | 0 | 0 | 8 |
| putative alpha-glucosidase | 1 | 0 | 0 | 1 |
| alpha-galactosidase | 4 | 0 | 0 | 4 |
| lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 7 | 0 | 0 | 7 |
| cellular tumor antigen p53 isoform a | 5 | 0 | 0 | 5 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| eukaryotic translation initiation factor 2-alpha kinase 3 isoform 1 precursor | 0 | 0 | 1 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 5 | 0 | 0 | 5 |
| M-phase phosphoprotein 8 | 5 | 0 | 0 | 5 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase Chk1 | 0 | 0 | 1 | 1 |
| Histone deacetylase 3 | 0 | 4 | 0 | 4 |
| Type-2 restriction enzyme ScaI | 0 | 1 | 0 | 1 |
| Deoxyribonuclease-2-alpha | 0 | 1 | 0 | 1 |
| Tyrosyl-DNA phosphodiesterase 2 | 0 | 1 | 0 | 1 |
| Deoxyribonuclease-1 | 0 | 1 | 0 | 1 |
| Type-2 restriction enzyme PstI | 0 | 1 | 0 | 1 |
| Type-2 restriction enzyme EcoRI | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 0 | 1 | 2 |
| DNA ligase | 0 | 1 | 0 | 1 |
| Heterogeneous nuclear ribonucleoprotein A1 | 0 | 0 | 1 | 1 |
| DNA topoisomerase 1 | 0 | 1 | 1 | 7 |
| DNA topoisomerase 2-alpha | 0 | 1 | 0 | 1 |
| Type-2 restriction enzyme BamHI | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 1 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 2 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 4 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 3 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 5 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 6 | 0 | 6 |
| Type-2 restriction enzyme HindIII | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 4 | 0 | 4 |
| Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| DNA topoisomerase 2-beta | 0 | 0 | 0 | 1 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 2 |
| Histone deacetylase 1 | 0 | 4 | 0 | 4 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
| Integrase | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 4 | 0 | 4 |
| Histone deacetylase 2 | 0 | 4 | 0 | 4 |
| DNA topoisomerase type IB small subunit | 0 | 0 | 1 | 1 |
| Polyamine deacetylase HDAC10 | 0 | 4 | 0 | 4 |
| Histone deacetylase 11 | 0 | 4 | 0 | 4 |
| Histone deacetylase 8 | 0 | 4 | 0 | 4 |
| Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 6 | 0 | 4 | 0 | 4 |
| Histone deacetylase 9 | 0 | 4 | 0 | 4 |
| Histone deacetylase 5 | 0 | 4 | 0 | 4 |
| Liver carboxylesterase 1 | 0 | 1 | 0 | 3 |
| Vpr | 2 | 0 | 0 | 2 |
| Albumin | 0 | 0 | 3 | 3 |
| Major prion protein | 0 | 0 | 2 | 2 |
| Sodium channel protein type 1 subunit alpha | 0 | 4 | 0 | 4 |
| Sodium channel protein type 2 subunit alpha | 0 | 5 | 0 | 5 |
| Sodium channel protein type 3 subunit alpha | 0 | 4 | 0 | 4 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 4 |
| Sodium channel protein type 4 subunit alpha | 0 | 5 | 0 | 8 |
| Sodium channel protein type 9 subunit alpha | 0 | 6 | 0 | 6 |
| Frizzled-8 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 4 | 1 | 5 |
| Alpha-2C adrenergic receptor | 0 | 6 | 1 | 7 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 1 | 1 |
| Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
| Ileal sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
| TAR DNA-binding protein 43 | 7 | 0 | 0 | 7 |
| Bile acid receptor | 0 | 0 | 1 | 1 |
| G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
| Bile acid receptor | 0 | 1 | 1 | 2 |
| Proteasome subunit beta type-11 | 0 | 0 | 0 | 1 |
| NADPH oxidase 1 | 0 | 1 | 0 | 1 |
| G | 9 | 0 | 0 | 9 |
| Snq2p | 0 | 0 | 0 | 1 |
| Adenylate cyclase type 1 | 0 | 2 | 0 | 2 |
| Spike glycoprotein | 0 | 1 | 2 | 3 |
| Replicase polyprotein 1ab | 0 | 1 | 2 | 3 |
| D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 8 | 0 | 0 | 8 |
| histone deacetylase 9 isoform 3 | 3 | 0 | 0 | 3 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| Proteasome subunit alpha type-7 | 0 | 0 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| Transmembrane protease serine 2 | 0 | 1 | 2 | 3 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 0 | 3 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 6 | 0 | 6 |
| 5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
| HLA class I histocompatibility antigen, B alpha chain | 9 | 0 | 0 | 9 |
| Albumin | 0 | 0 | 4 | 4 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 2 | 0 | 2 |
| Procathepsin L | 0 | 1 | 2 | 3 |
| Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
| Muscarinic acetylcholine receptor M2 | 0 | 3 | 0 | 3 |
| Muscarinic acetylcholine receptor M4 | 0 | 5 | 0 | 5 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 3 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 2 | 4 |
| Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 3 | 0 | 3 |
| Replicase polyprotein 1a | 0 | 1 | 2 | 3 |
| Replicase polyprotein 1ab | 0 | 1 | 2 | 3 |
| Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
| Cys-loop ligand-gated ion channel | 0 | 1 | 0 | 1 |
| Calmodulin-1 | 0 | 2 | 1 | 3 |
| Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M1 | 0 | 3 | 0 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 3 | 0 | 3 |
| Angiotensin-converting enzyme | 0 | 4 | 0 | 4 |
| D(2) dopamine receptor | 0 | 4 | 0 | 5 |
| Alpha-1B adrenergic receptor | 0 | 3 | 0 | 3 |
| Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
| D | 0 | 3 | 0 | 3 |
| D(3) dopamine receptor | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 1A | 0 | 6 | 0 | 7 |
| Alpha-2B adrenergic receptor | 0 | 3 | 0 | 3 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 4 | 0 | 4 |
| Proteasome subunit beta type-1 | 0 | 0 | 0 | 1 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 0 | 4 | 0 | 5 |
| D(4) dopamine receptor | 0 | 3 | 0 | 4 |
| D(1B) dopamine receptor | 0 | 1 | 0 | 2 |
| Adenylate cyclase type 3 | 0 | 2 | 0 | 2 |
| Alpha-2C adrenergic receptor | 0 | 3 | 0 | 3 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 3 | 0 | 3 |
| Alpha-1D adrenergic receptor | 0 | 3 | 0 | 3 |
| Sodium-dependent noradrenaline transporter | 0 | 6 | 0 | 6 |
| Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
| Histamine H2 receptor | 0 | 4 | 0 | 4 |
| Alpha-1D adrenergic receptor | 0 | 4 | 0 | 4 |
| D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
| Proteasome subunit alpha type-1 | 0 | 0 | 0 | 1 |
| Proteasome subunit alpha type-2 | 0 | 0 | 0 | 1 |
| Proteasome subunit alpha type-3 | 0 | 0 | 0 | 1 |
| Proteasome subunit alpha type-4 | 0 | 0 | 0 | 1 |
| Adenylate cyclase type 2 | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 4 | 0 | 2 | 0 | 2 |
| Proteasome subunit beta type-8 | 0 | 0 | 0 | 1 |
| Proteasome subunit beta type-9 | 0 | 0 | 0 | 1 |
| Proteasome subunit alpha type-5 | 0 | 0 | 0 | 1 |
| Proteasome subunit beta type-4 | 0 | 0 | 0 | 1 |
| Proteasome subunit beta type-6 | 0 | 0 | 0 | 1 |
| Proteasome subunit beta type-5 | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 1B | 0 | 4 | 0 | 4 |
| Trypanothione reductase | 0 | 2 | 0 | 2 |
| D(4) dopamine receptor | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 2 | 1 | 3 |
| Sodium-dependent serotonin transporter | 0 | 7 | 0 | 7 |
| Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
| Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
| Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 4 | 0 | 4 |
| Mu-type opioid receptor | 0 | 3 | 1 | 4 |
| D(3) dopamine receptor | 0 | 4 | 0 | 5 |
| Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 8 | 0 | 2 | 0 | 2 |
| Proteasome subunit beta type-10 | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 3 | 0 | 3 |
| Kappa-type opioid receptor | 0 | 3 | 0 | 3 |
| Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
| Alpha-1A adrenergic receptor | 0 | 3 | 0 | 3 |
| Histamine H2 receptor | 3 | 0 | 0 | 3 |
| Proteasome subunit beta type-3 | 0 | 0 | 0 | 1 |
| Proteasome subunit beta type-2 | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-6 | 0 | 0 | 1 | 2 |
| Calmodulin | 0 | 1 | 1 | 2 |
| Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 6 | 0 | 6 |
| Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
| Adenylate cyclase type 6 | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 5 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 0 | 3 |
| Aldehyde oxidase | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 6 | 0 | 6 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 7 | 0 | 7 |
| Sodium channel protein type 5 subunit alpha | 0 | 5 | 0 | 5 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 0 | 3 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 4 | 0 | 4 |
| Adenylyl cyclase 7 | 0 | 2 | 0 | 2 |
| Proteasome subunit alpha-type 8 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 0 | 3 |
| Inositol hexakisphosphate kinase 1 | 9 | 0 | 0 | 9 |
| D | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 3 | 0 | 3 |
| Proteasome subunit beta type-7 | 0 | 0 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 1 | 2 | 3 |
| Sodium channel protein type 3 subunit alpha | 0 | 4 | 0 | 4 |
| Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 2 | 0 | 2 |
| Sodium channel protein type 10 subunit alpha | 0 | 2 | 0 | 2 |
| cytochrome P450 2C9, partial | 9 | 0 | 0 | 9 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Putative Glycine Betaine-binding Abc Transporter Protein | 0 | 0 | 1 | 1 |
| Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, Choline-binding protein | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 3 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 3 | 0 | 3 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 3 | 0 | 3 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 3 | 0 | 3 |
| Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
| Choline O-acetyltransferase | 0 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-9 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
| High affinity choline transporter 1 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-10 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 5 | 2 | 7 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 5 | 0 | 5 |
| Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
| endonuclease IV | 5 | 0 | 0 | 5 |
| glp-1 receptor, partial | 5 | 0 | 0 | 5 |
| LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 2 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 2 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 8 | 0 | 0 | 8 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 2 | 0 | 2 |
| nuclear receptor coactivator 3 isoform a | 0 | 2 | 0 | 2 |
| Thymidine kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 4 | 0 | 5 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Deoxycytidine kinase | 0 | 0 | 0 | 2 |
| Probable deoxycytidylate deaminase | 0 | 0 | 0 | 2 |
| Cytidine deaminase | 0 | 1 | 0 | 3 |
| E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
| Deoxynucleoside kinase | 0 | 1 | 0 | 1 |
| Thymidine kinase 2 | 0 | 1 | 0 | 1 |
| AAA family ATPase | 0 | 0 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 4 | 6 | 20 |
| Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
| Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
| Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| Alpha-synuclein | 2 | 2 | 0 | 4 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 4 | 4 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
| Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
| Chain B, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
| Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
| Chain B, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
| Chain A, Pol Polyprotein | 0 | 1 | 0 | 1 |
| Chain B, Pol Polyprotein | 0 | 1 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 2 | 4 | 0 | 0 | 4 |
| neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
| Prothrombin | 0 | 1 | 0 | 1 |
| Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
| Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Microsomal triglyceride transfer protein large subunit | 0 | 1 | 0 | 1 |
| Envelope glycoprotein gp160 [Cleaved into: Surface protein gp120 | 0 | 1 | 0 | 1 |
| Protease | 0 | 1 | 1 | 3 |
| Fructose-1,6-bisphosphatase 1 | 0 | 0 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 3 |
| Reverse transcriptase | 0 | 1 | 1 | 2 |
| Cholesterol 24-hydroxylase | 0 | 0 | 1 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
| UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 2 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B15 | 0 | 0 | 0 | 1 |
| Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 2 | 0 | 2 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 5 |
| Pantothenate synthetase | 0 | 2 | 0 | 2 |
| pregnane X receptor | 5 | 0 | 0 | 5 |
| NADH-ubiquinone oxidoreductase chain 1 | 0 | 1 | 0 | 1 |
| Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Skn7p | 0 | 0 | 0 | 1 |
| nonstructural protein 1 | 2 | 0 | 0 | 2 |
| urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
| plasminogen precursor | 2 | 0 | 0 | 2 |
| urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| Amyloid-beta precursor protein | 1 | 2 | 0 | 3 |
| Aromatase | 0 | 1 | 0 | 1 |
| HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
| Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
| acid sphingomyelinase | 2 | 0 | 0 | 2 |
| DNA polymerase beta | 2 | 0 | 0 | 2 |
| Thymidylate synthase | 0 | 4 | 0 | 4 |
| Dihydrofolate reductase | 0 | 4 | 3 | 7 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 4 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 4 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 4 |
| Multidrug resistance associated protein | 0 | 1 | 0 | 3 |
| Gamma-aminobutyric acid | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit rho-3 | 0 | 0 | 1 | 1 |
| Hsf1 protein | 0 | 0 | 3 | 4 |
| bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 1 | 2 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit rho-1 | 0 | 0 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit rho-2 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent taurine transporter | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 1 | 2 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
| Sterol O-acyltransferase 1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 1 | 2 |
| Platelet glycoprotein VI | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 1 | 2 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 1 | 0 | 1 |
| Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | 0 | 1 | 0 | 1 |
| Chain A, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
| Chain B, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
| Chain A, Slr1257 protein | 0 | 0 | 1 | 1 |
| Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] | 0 | 1 | 0 | 1 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| Metabotropic glutamate receptor 8 | 0 | 2 | 0 | 2 |
| Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
| Bifunctional aspartokinase/homoserine dehydrogenase 1 | 0 | 1 | 0 | 1 |
| ATP-citrate synthase | 0 | 1 | 0 | 1 |
| Glutamate receptor 1 | 0 | 2 | 1 | 3 |
| Glutamate receptor 3 | 0 | 2 | 1 | 3 |
| Glutamate receptor 4 | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 1 | 3 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 2 |
| Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 3 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 2 |
| Metabotropic glutamate receptor 5 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 7 | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, kainate 1 | 0 | 1 | 1 | 2 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 3 |
| Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 1 | 3 |
| Glutamate receptor 1 | 0 | 2 | 1 | 3 |
| Glutamate receptor 2 | 0 | 2 | 1 | 3 |
| Glutamate receptor 3 | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 3 | 0 | 2 | 0 | 2 |
| Metabotropic glutamate receptor 8 | 0 | 0 | 1 | 1 |
| Glutamate receptor 4 | 0 | 2 | 1 | 3 |
| Excitatory amino acid transporter 3 | 0 | 0 | 0 | 1 |
| Glutamate racemase | 0 | 0 | 0 | 1 |
| Metabotropic glutamate receptor 8 | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 4 | 0 | 2 | 0 | 2 |
| Glutamate carboxypeptidase 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 2 | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 7 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 3 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 3 |
| Glutamate receptor ionotropic, kainate 5 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 5 | 0 | 2 | 0 | 2 |
| Glutamate racemase | 0 | 0 | 0 | 1 |
| Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
| Chain B, Pulmonary surfactant-associated protein D | 0 | 1 | 0 | 1 |
| Chain A, Pulmonary surfactant-associated protein D | 0 | 1 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
| Sodium/myo-inositol cotransporter 2 | 0 | 1 | 0 | 1 |
| Chain A, BETA-SPECTRIN | 0 | 0 | 1 | 1 |
| Chain A, Phospholipase C Delta-1 | 0 | 0 | 1 | 1 |
| Chain A, Inositol 1,4,5-trisphosphate receptor type 1 | 0 | 0 | 1 | 1 |
| Inositol-trisphosphate 3-kinase A | 0 | 1 | 0 | 1 |
| Inositol 1,4,5-trisphosphate receptor type 1 | 0 | 0 | 2 | 2 |
| Inositol 1,4,5-trisphosphate receptor type 2 | 0 | 1 | 0 | 1 |
| Inositol 1,4,5-trisphosphate receptor type 3 | 0 | 1 | 1 | 2 |
| Inositol polyphosphate-5-phosphatase A | 0 | 1 | 0 | 1 |
| Inositol 1,4,5-trisphosphate receptor type 1 | 0 | 1 | 1 | 2 |
| Chain A, Acetylcholinesterase | 0 | 1 | 0 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Interstitial collagenase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
| Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
| N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
| Formamidopyrimidine-DNA glycosylase | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| Macrophage migration inhibitory factor | 0 | 1 | 0 | 1 |
| Endonuclease III-like protein 1 | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 2 | 0 | 2 |
| DNA gyrase subunit A | 0 | 2 | 0 | 2 |
| Isocitrate lyase | 0 | 1 | 0 | 1 |
| Putative FAD-containing monooxygenase MymA | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Endonuclease 8-like 1 | 0 | 1 | 0 | 1 |
| 7,8-dihydro-8-oxoguanine triphosphatase | 0 | 1 | 0 | 1 |
| Capsid protein | 0 | 1 | 2 | 3 |
| Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 2 | 0 | 2 |
| Chain A, AMINOPEPTIDASE | 0 | 2 | 0 | 2 |
| Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| Intestinal-type alkaline phosphatase | 0 | 2 | 0 | 2 |
| Large neutral amino acids transporter small subunit 1 | 0 | 4 | 0 | 5 |
| Phospholipase A-2-activating protein | 0 | 2 | 0 | 2 |
| chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
| Synaptic vesicle glycoprotein 2A | 0 | 2 | 0 | 2 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
| WRN | 1 | 0 | 0 | 1 |
| integrase, partial | 0 | 1 | 0 | 1 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| importin subunit beta-1 isoform 1 | 3 | 0 | 0 | 3 |
| snurportin-1 | 3 | 0 | 0 | 3 |
| DNA polymerase eta isoform 1 | 3 | 0 | 0 | 3 |
| Plasma kallikrein | 0 | 0 | 0 | 2 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 2 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 2 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| Potassium channel subfamily K member 3 | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| Toll-like receptor 4 | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Folate receptor beta | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Folate receptor alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Histidine decarboxylase | 0 | 1 | 0 | 1 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
| Multidrug resistance-associated protein 1 | 0 | 0 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Reduced folate transporter | 0 | 2 | 0 | 2 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
| Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 2 |
| Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
| tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| Serine racemase | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 6 | 2 | 13 |
| Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
| Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
| Thioredoxin reductase | 0 | 1 | 0 | 1 |
| Flavodoxin | 0 | 0 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| Sialidase-4 | 0 | 1 | 0 | 1 |
| Sialidase-1 | 0 | 1 | 0 | 1 |
| Sialidase-3 | 0 | 1 | 0 | 1 |
| Sialidase-2 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| 5'-nucleotidase | 0 | 1 | 0 | 1 |
| E3 ubiquitin-protein ligase XIAP | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 2 |
| Voltage-dependent calcium channel subunit alpha-2/delta-2 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-6 | 0 | 1 | 0 | 1 |
| Pyridoxal kinase | 0 | 0 | 0 | 1 |
| Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
| Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
| Beta-lactoglobulin | 0 | 0 | 1 | 1 |
| NS5 | 0 | 0 | 1 | 1 |
| Polymerase basic protein 2 | 0 | 0 | 1 | 1 |
| RNA-directed RNA polymerase catalytic subunit | 0 | 0 | 1 | 1 |
| Polymerase acidic protein | 0 | 0 | 1 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 0 | 1 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Arylacetamide deacetylase | 0 | 1 | 0 | 2 |
| Caspase-1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 2 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Transporter | 0 | 1 | 0 | 1 |
| Adenylate kinase isoenzyme 1 | 0 | 0 | 0 | 1 |
| Adenylate kinase 2, mitochondrial | 0 | 0 | 0 | 1 |
| Chain A, ykoF | 0 | 0 | 1 | 1 |
| Chain B, ykoF | 0 | 0 | 1 | 1 |
| Chain A, ThiT | 0 | 0 | 1 | 1 |
| Thiamine transporter ThiT | 0 | 0 | 1 | 1 |
| Transketolase | 0 | 0 | 1 | 1 |
| Thiamine-binding periplasmic protein | 0 | 0 | 1 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
| Transthyretin | 0 | 1 | 0 | 2 |
| Thyroid hormone receptor alpha | 0 | 0 | 1 | 1 |
| Thyroid hormone receptor beta | 0 | 0 | 1 | 1 |
| Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 2 | 2 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
| Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with trehalose | 0 | 1 | 0 | 1 |
| Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with cellobiose | 0 | 1 | 0 | 1 |
| Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with maltose | 0 | 1 | 0 | 1 |
| Trehalose-phosphatase | 0 | 1 | 0 | 1 |
| Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
| Cocaine esterase | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
| Ectonucleoside triphosphate diphosphohydrolase 1 | 0 | 0 | 0 | 1 |
| Protein kinase C beta type | 0 | 1 | 0 | 1 |
| DNA polymerase beta | 0 | 1 | 0 | 1 |
| Thymidine kinase, cytosolic | 0 | 0 | 0 | 1 |
| Thymidylate kinase | 0 | 1 | 0 | 1 |
| Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |